Optimal concentration range of golimumab in patients with axial spondyloarthritis.


OBJECTIVES To investigate the association between serum golimumab (GLM) trough levels, clinical disease activity and treatment response during the first year of therapy in patients with axial spondyloarthritis (axSpA), as well as determining an optimal concentration range of GLM in axSpA. METHODS This was an observational prospective study including 49… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.